Related Experiment Videos
Metrizamide in high-dose urography
Abstract:
The non-ionic water-soluble contrast medium metrizamide (Amipaque) was used for high-dose urography in 11 patients with apparently normal renal function. Films of good quality were obtained. Adverse reactions and the effect on pulse and blood pressure as well as a large number of blood and urine laboratory parameters were recorded. Only clinically insignificant effects occurred, and the medium is recommended for further use in urography.
Insights
Metrizamide (Amipaque), a non-ionic contrast medium, proved safe for high-dose urography in patients with normal kidney function. This study found only minor side effects, recommending its continued use in diagnostic imaging.
Area of Science:
- Radiology
- Medical Imaging
- Urology
Background:
- Metrizamide (Amipaque) is a non-ionic, water-soluble contrast medium.
- Urography is a key diagnostic imaging technique for the urinary tract.
Purpose of the Study:
- To evaluate the safety and efficacy of high-dose metrizamide (Amipaque) for urography.
- To assess adverse reactions and physiological effects in patients with normal renal function.
Main Methods:
- 11 patients with normal renal function underwent high-dose urography using metrizamide (Amipaque).
- Quality of imaging films was assessed.
- Adverse reactions, pulse, blood pressure, and laboratory parameters (blood and urine) were monitored.
Main Results:
- Good quality films were consistently obtained.
- Only clinically insignificant adverse reactions were observed.
- No significant adverse effects on pulse, blood pressure, or laboratory parameters were noted.
Conclusions:
- High-dose metrizamide (Amipaque) is a safe and effective contrast medium for urography in patients with normal renal function.
- The medium is well-tolerated with minimal side effects.
- Recommended for further clinical use in urography.